| P |
|
Pneumocystis carinii pneumonia in HIV-negative patients
|
| Kofteridis D., Velegraki M., Antoniou M., Papazoglou G., Anastasopoulos T., Alegakis D., Samonis G. |
| |
|
Propionibacterium acnes endocarditis
|
| Gray A.L., Sohail M.R., Baddour L.M., Virk A. |
| |
|
Pseudomonas aeruginosa in German intensive care units
|
| Meyer E., Schwab F., Gastmeier P., Rueden H., Jonas D. |
| |
|
Pseudomonas aeruginosa resistance rates in association with level of hospital care: data from the EARSS
|
| Tiemersma E.W., van de Sande N., Kahlmeter G., de Kraker M., Monen J., Grundmann H., participants EARSS |
| |
|
Pseudomonas aeruginosa utilises its type III secretion system to kill the free-living amoeba Acanthamoeba castellanii
|
| Saeed A., Abd H., Wretlind B., Sandström G. |
| |
|
Pseudomonas aeruginosa with a novel blaVIM-4/blaP1b and a second class-1 integron, efflux pumps overexpression and repressed porin OprD
|
| Maniati M., Ikonomidis A., Mantzana P., Maniatis A., Pournaras S. |
| |
|
Pseudomonas aeruginosa: don't go near the water
|
| Dettenkofer M. |
| |
|
Panchlamydia PCR for detection and identification of Chlamydia trachomatis, Chlamydophila pneumoniae, and Chlamydophilia psittaci by LightCycler PCR
|
| Juretzek T., Buder J., Bär W. |
| |
|
Pandemic flu preparedness role of antibiotics
|
| McIntosh E., Wu D., Paradiso P., Tucker H., Burlington B., Brenner R., Clarke J., Cooke J., Puz P., Temple M., Papiernik D., Mallick R., Kuznik A., Barrett L., Woodrow A. |
| |
|
Parallel- and cross-resistance of the azoles fluconazole, itraconazole, kezoconazole, voriconazole, and of fluconazole to clinical yeast isolates
|
| Schmalreck A.F., Becker K., Fegeler W. |
| |
|
Parenteral colistin: finally a useful drug?
|
| Jacobs F. |
| |
|
Pathogenic Yersinia enterocolitica widely distributed in finishing pigs at slaughter in Switzerland
|
| Fredriksson-Ahomaa M., Stolle A., Stephan R. |
| |
|
Pathogenicity of viridans streptococci in three murine in vivo models
|
| Genzel G., Beer J., Rüdiger T., Schaumann R., Nitsche-Schmitz P.D., Chhatwal G.S., Rodloff A.C. |
| |
|
Pathogen-related association of mannose-binding lectin deficiency with community-acquired pneumonia
|
| Herpers B.L., Endeman H., de Jong B.A.W., van Hannen E.J., Rijkers G.T., van Velzen-Blad H., Biesma D.H., Grutters J.C., Voorn G.P., de Jongh B.M. |
| |
|
Pathogens and resistance
|
| Matsumoto T. |
| |
|
Patient demand for antibiotic prescription. An often-neglected cause of antibiotic resistance in the community
|
| Alevizos A., Perimeni D., Larios G., Mihas C., Fanou D., Papathanasiou M., Trifynopoulou K., Stamatiou K., Kintzoglanakis K., Mariolis A. |
| |
|
Patients with chronic fatigue syndrome have higher numbers of anaerobic bacteria in the intestine compared to healthy subjects
|
| Evengård B., Nord C.E., Sullivan Å. |
| |
|
Patterns of susceptibility of Gram-negatives/positives isolated in the United Kingdom and Ireland
|
| Johnson B., Bouchillon S., Hackel M., Badal R., Johnson J., Hoban D., Dowzicky M. |
| |
|
PCR of the 16S rRNA gene and DNA sequencing in establishing the aetiology of bacterial infections in children
|
| Gleesen A., Grarup C. |
| |
|
PCR with universal primers targeting the small ribosomal RNA (16S rRNA) gene of bacteria as a diagnostic tool in 15 hospitalised patients with infectious diseases
|
| Longhi E., Foschi A., Bestetti G., Acquaviva V., Radice A., Parravicini C., Antinori S., Corbellino M. |
| |
|
Penetration and activity of fosfomycin, ciprofloxacin, amoxicillin plus clavulanic acid and cotrimoxazol in Escherichia coli and Pseudomonas aeruginosa biofilms
|
| Rodriguez-Martinez J., Ballesta S., Pascual A. |
| |
|
Penetration of moxifloxacin and lomefloxacin into the prostatic tissue and fluid
|
| Yakovlev S., Komarov R., Izotova G., Yakovlev V. |
| |
|
Penetration of telavancin into pulmonary epithelial lining fluid and alveolar macrophages
|
| Wong S., Shaw J., Gotfried M., Barriere S., Kitt M., Goldberg M. |
| |
|
Perception of adverse-effect risks and receipt of influenza vaccination among hospital personnel
|
| Ehrenstein B.P., Hanses F., Blaas S., Mandraka F., Audebert F., Salzberger B. |
| |
|
Performance evaluation of a novel enzyme immunoassay for detection of human metapneumovirus
|
| Sheridan M. |
| |
|
Performance evaluation of the QIAGEN EZ1 DSP virus kit with Abbott RealTime HIV-1, HCV and HBV assays
|
| Schneider G., Kuper K., Abravaya K., Mullen C., Schmidt M., Sprenger-Haussels M. |
| |
|
Performance evaluation of the Vidia toxoplasmosis IgG and IgM assays
|
| Calderaro A., Piccolo G., Peruzzi S., Dettori G., Chezzi C. |
| |
|
Performance evaluation of VIDIA HBs Ag, a new automated immunoassay test for the qualitative detection of HBs antigen in serum and plasma human samples
|
| Seignères B., Ripoll N., Gradon P., Desmottes P. |
| |
|
Performance evaluation of VIDIA HIV DUO, a new automated immunoassay test for the qualitative HIV antigen/antibodies detection in serum and plasma human samples
|
| Briand H., Vayssié F., Breton-Laval O., Dugua J.M., Lacoux X., Battail-Poirot N., Gradon P., Piche J. |
| |
|
Performance of a new molecular assay for detection and differentiation of Bordetella spp. DNA
|
| Koidl C., Bozic M., Kessler H.H., Marth E. |
| |
|
Performance of an automated chemiluminescent assay for the detection of anti-hepatitis A virus IgM antibodies: Access® HAV IgM assay
|
| Buisson Y., Masson C., Bouniort F. |
| |
|
Performance of MRSA ID chromogenic medium for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures and clinical specimens
|
| Colakoglu S., Uncu H., Senger S., Turunc T., Demiroglu Y., Arslan H. |
| |
|
Performance of the GeneXpert® system for detection of methicillin-resistant Staphylococcus aureus including the non-typeable clone from animal origin
|
| Wassenberg M.W.M., Nijssen S., Huijsdens X.W., Bergmans A.M.C., Vandenbroucke-Grauls C.M.J.E., Bonten M.J.M., Kluytmans J.A.J.W. |
| |
|
Periodontal pathogenic bacteria in oral microflora of halitosis patients in Latvia
|
| Rostoka D., Kroica J., Reinis A., Kuznecova V. |
| |
|
Periorbital cellulitis: two-year review of eleven hospitalised patients
|
| Gundes S.S., Cetin Akhan S.S. |
| |
|
Permanent pacemaker and implantable cardioverter-defibrillator-related infective endocarditis
|
| Sohail M., Uslan D., Khan A., Friedman P., Hayes D., Wilson W., Steckelberg J., Stoner S., Baddour L. |
| |
|
Persistence of the poliovirus genome in the cerebrospinal fluid of patients affected by post-polio syndrome
|
| Baj A., Monaco S., Zanusso G., Molteni F., Toniolo A. |
| |
|
Persistent bacteraemic infective endocarditis
|
| Findova L., Demitrovicova A., Krcmery V., Kisac P., Marks P. |
| |
|
Persistent suppression of bacterial growth after exposure to high-frequency alternated current
|
| Cassanelli C., Roveta S., Marchese A., Debbia E.A. |
| |
|
Pertactin evaluation as immunogen in murine model
|
| Rosales E., Fernandez-Ramirez A., Barcenas-Morales G., Montaraz-Crespo J. |
| |
|
PET-CT scan in patients with infective endocarditis for early detection of embolisation and metastatic infection
|
| Hill E., D'Hondt E., Crevits J.H.G., Vanderschueren S., Herregods M-C., Herijgers P., Dymarkowski S., Mortelmans L., Peetermans W.E. |
| |
|
Phagocyte Fcg receptors expression in bacteraemia
|
| Garcia-Egido A.A., Escobar M.A., Fernandez F.J., Gomez-Soto F.M., Ruiz P., Rosety M., Rivera C., Gomez F. |
| |
|
Pharmacodynamic comparison of linezolid, teicoplanin, and vancomycin against clinical isolates of Staphylococcus aureus and coagulase negative staphylococci collected from hospitals in Brazil
|
| Kiffer C., Kuti J., Mendes C., Sinto S., Koga P., Nicolau D. |
| |
|
Pharmacodynamic evaluation of 7 antimicrobials recommended for secondary peritonitis, including the novel agent tigecycline, using global resistance data
|
| Eagye K.J., Kuti J.L., Dowzicky M., Nicolau D.P. |
| |
|
Pharmacodynamics of gentamicin against Pseudomonas aeruginosa: modelling bacterial response to drug-selective pressures
|
| Tam V.H., Vo G., Kabbara S., Nikolaou M. |
| |
|
Pharmaco-economic impact accounting for future resistance of ertapenam vs. piperacillin/tazobactam in the treatment of community-acquired complicated intra-abdominal infections in the Netherlands
|
| Jansen J., Kumar R., Carmeli Y. |
| |
|
Pharmacokinetic interaction and dose adjustment for combined use of voriconazole and efavirenz
|
| Damle B., LaBadie R., Crownover P., Glue P. |
| |
|
Pharmacokinetic parameters of 400/100 mg indinavir/ritonavir in HIV-infected Thai patients
|
| Jaruratanasirikul S. |
| |
|
Pharmacokinetic profiles in chronic hepatitis C patients treated with high-dose pegylated interferon
|
| van der Eijk A., Vrolijk J., de Knegt R., Schalm S., Osterhaus A., Haagmans B. |
| |
|
Pharmacokinetic study of ertapenem in the biliary tract
|
| Skiada A., Chardaloubas D., Dimitroulis D., Smyrnis A., Anyfantis J., Grammatikou M., Petrikkou E., Papachristodoulou A., Petrikkos G. |
| |
|
Pharmacokinetic/pharmacodynamic modelling of the plasma bactericidal activity of NXL103 against Streptococcus pneumoniae and Staphylococcus aureus in phase I studies
|
| Merdjan H., Lowther J., Girard A-M., Delachaume C., Rangaraju M. |
| |
|
Pharmacokinetics of atazanavir in HIV-HCV co-infected patients with or without cirrhosis
|
| Gatti F., Loregian A., Nasta P., Pagni S., Prestini K., Matti A., Parisi S.G., Biasi L., Puoti M., Boldrin C., Palù G., Carosi G. |
| |
|
Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended release and immediate release formulations in patients with acute bacterial sinusitis
|
| Ehnhage A., Rautiainen M., Fang A., Sanchez S. |
| |
|
Pharmacokinetics of ceftobiprole following single and multiple intravenous infusions administered to healthy subjects
|
| Murthy B., Skee D., Wexler D., Balis D., Chang I., Desai-Kreiger D., Noel G. |
| |
|
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks
|
| Muller A.E., DeJongh J., Bult Y., Goessens W.H., Mouton J.W., Danhof M., van den Anker J.N. |
| |
|
Pharmacokinetics of teicoplanin in Chinese patients undergoing CAPD
|
| Qi H., Ma X., Zhang P., Gao L., Cui H., Hou F. |
| |
|
Pharmaeconomics of aspergillosis after liver transplantation: a descriptive evaluation
|
| Rosenhagen M., Feldhues R., Geiss H.K., Hoppe-Tichy T. |
| |
|
Pharmakokinetics of voriconazole in an intensive care unit patient with liver cirrhosis
|
| Weiler S., Bellmann-Weiler R., Bellmann R. |
| |
|
Phenotypic and genotypic characterisation of antimicrobial resistance in Turkish Salmonella infantis isolates from chicken and minced meat
|
| Avsaroglu D., Junker E., Helmuth R., Schroeter A., Akcelik M., Bozoglu F., Noeckler K., Guerra B. |
| |
|
Phenotypic characteristics of 357 consecutively collected human isolates of Fusobacterium necrophorum ssp. funduliforme from Denmark
|
| Jensen A., Kristensen L.H., Prag J. |
| |
|
Phenotypic detection of AmpC in E. coli: comparison of cloxacillin, boronic acid and EDTA disk synergy assays
|
| Giske C., Haldorsen B., Lundblad E., Aasnæs B., Simonsen G., Sundsfjord A. |
| |
|
Phenotypic versus genotypic identification of bacteria in the clinical microbiology laboratory: the possible impact on patient care
|
| Adler A., Temper V., Moses A.E., Nahor O., Zimchoni O., Block C. |
| |
|
Phenotypical expression of extended spectrum b-lactamases in Enterobacteriaceae: prevalence in 3 university hospitals in Germany, 20032006 and implications for screening
|
| Endres A.-S., Noll I., Eckmanns T., Pfister W., Wellinghausen N., Ziesing S., Krause G. |
| |
|
Phylogenetic groups, antibiotic susceptibility, biofilm formation and PFGE in Escherichia coli from community-acquired cystitis
|
| Ejrnaes K., Reisner A., Lundgren B., Ferry S., Holm S., Monsen T., Lundholm R., Frimodt-Moller N. |
| |
|
Phylogenetic, clinical and virological features of hepatitis B virus among Iranian HBsAg carriers
|
| Bahramali G., Sadeghi-Zadeh M., Amini-Bavil-Olyaee S., Alavian S., Behzad-Behbahani A., Rabbani B., Sabouri E., Barkhordari F., Bagheri R., Mahboudi F. |
| |
|
Physician adherence to pneumonia guidelines regarding initial regimen choice
|
| Peppas T.A., Matsoukas P., Vlastari H., Sotiropoulos A., Binikos I.D., Kandyla B.D., Tamvakos I., Pappas S.I. |
| |
|
Pilot evaluation of Innovotech bioFILM PA susceptibility test for clinical utility in the treatment of cystic fibrosis patients infected with Pseudomonas aeruginosa
|
| Rennie R.P., Turnbull L., Brosnikoff C., Brown N.E., Lien D.C., Rawal B., Olson M. |
| |
|
Pitfalls in molecular detection of human respiratory syncitial virus
|
| Vankeerberghen A., Boel A., De Beenhouwer H. |
| |
|
PK/PD in critically ill patients
|
| Scaglione F. |
| |
|
PK/PD modelling of linezolid against MRSA
|
| Schmidt S. |
| |
|
PK-PD parameters ratio of antibiotics released from antibiotic-loaded spacers in drainage fluids
|
| Bertazzoni Minelli E., Benini A., Magnan B., Bartolozzi P. |
| |
|
Plasma is to be preferred above whole blood for automated nucleic acid extraction using the Nuclisens EasyMag system (Biomérieux)
|
| Ursi D., Bergs K., Goossens H., Ieven M. |
| |
|
Plasmid analysis and location of the OXA-40 carbapenemase gene in multidrug-resistant endemic clones of Acinetobacter baumannii
|
| Sevillano E., Valderrey C., Rosales I., Fernandez E., Calvo F., Gallego L. |
| |
|
Plasmid location of blaOXA-40 gene in Acinetobacter baumannii and Acinetobacter haemolyticus
|
| Quinteira S., Grosso F., Peixe L. |
| |
|
Plasmid-mediated AmpC b-lactamases in Enterobacteriaceae lacking a chromosomal ampC gene and E. coli: prevalence at a Swiss university hospital and distribution of the different molecular types in the northern part of Switzerland
|
| Adler H., Fenner L., Hohler D., Frei R. |
| |
|
Plasmid-mediated quinolone resistance determinants, QnrA, QnrB, and QnrS, among clinical isolates of Enterobacter cloacae in a Taiwanese hospital
|
| Yan J., Wu J., Ko W., Tsai S. |
| |
|
Plasmid-mediated quinolone resistance in non-typhi serotypes of Salmonella enterica in Ireland in 2001May 2006
|
| O'Connor J., Morris D., DeLappe N., Doran G., Cormican M. |
| |
|
Plasmids in clinically-significant Gram-negative bacteria
|
| Carattoli A. |
| |
|
pncA and rpoB mutations in Mycobacteriumtuberculosis, a 3-year experiment in Lyon, France
|
| Mignard S., Carret G., Chomarat M., Fredenucci I., de Montclos M., Flandrois J. |
| |
|
Pneumococcal empyema in Toronto, Canada, 19952006
|
| Lee T., Green K., McGeer A., Low for the Toronto Invasive Bacterial Diseases Network D. |
| |
|
Pneumococcal invasive isolates of non-vaccine serotypes in Italy, 19992003 (pre-vaccine era)
|
| Gherardi G., Monaco M., Camilli R., D'Ambrosio F., D'Ancona P., Manganelli R., Dicuonzo G., Pantosti A. |
| |
|
Pneumococcal meningitis in Taiwanese children: emphasis on clinical outcomes and prognostic factors
|
| Tsai M.H., Chen S.H., Hsu C.Y., Yan D.C., Yen M.H., Chiu C.H., Huang Y.C., Lin T.Y. |
| |
|
Pneumococcal meningitis is a cause of death in patients with severe liver cirrhosis
|
| Pagliano P., Fusco U., Attanasio V., Rossi M., Conte M., Faella F. |
| |
|
Pneumococcal meningitis: is disease severity related to capsular or clonal types?
|
| Ribes S., Taberner F., Cabellos C., Gerber J., Tubau F., Ardanuy C., Liñares J., Nau R., Gudiol F. |
| |
|
Point prevalence study of the spectrum of infectious diseases and antimicrobial drugs use in homogeneous slum population of Mukuru in Nairobi
|
| Kandrava K., Svabova V., Bartkovjak M., Kutna K., Kolenova A., Krumpolcova M., Pivarnik M., Svitkova A., Njambi Z., Kamoche S., Kiwou M., Krcmery V., Kisac P. |
| |
|
Polyclonal distribution of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm
|
| Titelman E., Iversen A., Lagergren Å., Kühn I., Kahlmeter G., Giske C. |
| |
|
Pooled analysis of retrospective and prospective data on levofloxacin vs. other antibiotics in the treatment of hospitalised patients with pneumonia
|
| Lode H. |
| |
|
Population approach to antibiotic use for children in Lithuania
|
| Berzanskyte A., Valinteliene R. |
| |
|
Population structure of Spanish mef-PCR positive Streptococcus pneumoniae clinical isolates
|
| Gómez G-de la Pedrosa E., van der Linden M., Morosini M.I., Galán J.C., Baquero F., Reinert R.R., Cantón R. |
| |
|
Possible BK virus outbreak in haematopoietic stem cell transplant recipients
|
| Sonmezoglu M., Yirmibescik S., Obek C., Colak D., Kocagoz T., Koc Y. |
| |
|
Potential impact of pneumococcal vaccination in Denmark
|
| Harboe Z.B., Valentiner-Branth P., Hjuler T., Christensen J.J., Lambertsen L., Mølbak K., Konradsen H.B. |
| |
|
Potential role of TDM in dosing protease inhibtors in HIV-HCV co-infected patients with or without cirrhosis
|
| Gatti F., Pagni S., Nasta P., Boldrin C., Matti A., Loregian A., Biasi L., Puoti M., Parisi S.G., Prestini K., Palù G., Carosi G. |
| |
|
Praziquantel in prevention of complicated echinococcosis relapses
|
| Dautovic S., Koluder N., Ferhatovic M., Mostarac N., Kapisazovic S., Tanovic H., Mesic A., Gojak R. |
| |
|
Pre-admission penicillin in patients with meningitis or meningococcal disease
|
| Darville J.M., Lovering A.M., MacGowan A.P. |
| |
|
Pre-admission use of statins and mortality within 90 days after hospitalisation with pneumonia: population-based cohort study of 29,900 adult patients
|
| Thomsen R.W., Riis A., Kornum J.B., Christensen S., Johnsen S.P., Sørensen H.T. |
| |
|
Precise identification and phylogenetic relationships of major multi-resistant clones of Acinetobacter baumannii by multilocus sequence typing
|
| Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. |
| |
|
Preclinical pharmacokinetics and interspecies scaling of EDP-420, a first-in-class bicyclolide
|
| Jiang L.J., Wang G., Phan L., Sonderfan A., Paris M., Or Y.S. |
| |
|
Predicting Clostridium difficile toxin in hospitalised patients with antibiotic-associated diarrhoea
|
| Bishara J., Peled N., Samra Z., Pitlik S. |
| |
|
Predicting sepsis mortality in the emergency department: a comparison among mortality in emergency department sepsis (MEDS) score, procalcitonin, and C-reactive protein
|
| Lee C-C., Chen S-Y., Hsueh P-R. |
| |
|
Prediction of the tuberculosis reinfection rate from the local incidence
|
| Hsueh P.R., Wang J.Y., Lee L.N., Lai H.C., Hsu H.L., Liaw Y.S., Yang P.C. |
| |
|
Predictive risk factors for amputation in diabetic fetid foot infections
|
| Barberan J., Sanchez B., Menendez M.A., Toral J.R., Fe A., Fraile I., Alguacil R., Martinez D., Prieto J. |
| |
|
Predictive value of C-reactive protein and procalcitonin for bacteraemia in adult community-acquired infection
|
| Chen S.-Y., Chiang W.-C., Sun H.-Y., Wang J.-L., Chang S.-C., Lee C.-C., Yen A.M.-F., Wu G.H.-M., Chen T.H.-H., Hsueh P.-R. |
| |
|
Predictors of positive blood culture in an emergency service. A prospective study
|
| Ceballos B., Peralta G., Ansorena L., Rodriguez-Lera M., Roiz M., Sánchez M. |
| |
|
Predictors of positive microbiology in community-acquired pneumonia subjects: results of a multivariate analysis
|
| Garau for the MOTIV Study Group J. |
| |
|
Preferential sites of eschar for scrub typhus
|
| Kim D.M., Lee S.H. |
| |
|
Preliminary evaluation of a PCR protocol to directly detect Streptococcus equi ssp. zooepidemicus in equine specimens
|
| Preziuso S., Bastianini L., Laus F., Cuteri V. |
| |
|
Preliminary feasibility study of MIC results obtained with Staphylococcus aureus and cefoxitin using an Investigational Use Only MicroScan Dried Overnight Panel
|
| Sei K., Bains H., Zimmer B. |
| |
|
Preparation of recombinant antigen from Orientia tsutsugamushi Ptan strain and development of rapid diagnostic reagent of scrub typhus
|
| Tang J. |
| |
|
Preparation of the herpes simplex virus type 2 glycoprotein D subunit and DNA vaccines and evaluation of their efficacy in guinea pigs
|
| Fotouhi F., Soleimanjahi H., Roostaee M., Dalimi A. |
| |
|
Presence of a pneumococcus-like capsulation locus in viridans group streptococci
|
| Van Eldere J., Janssen P., Massonet C., Pintens V., Merckx R. |
| |
|
Presence of dengue virus genome in the bone marrow of asymptomatic adults in a dengue-hyperendemic country: implication for complicated dengue pathogenesis
|
| Putcharoen O., Krajiw S., Nilratanakul V., Rojnuckarin P., Bhattarakosol P., Nisalak A., Pancharoen C., Thisyakorn U., Kulwichit W. |
| |
|
Presence of family phage-like elements conferring efflux-mediated macrolide resistance in group G streptococci
|
| Figueiredo T.A., Pinho M.D., Melo-Cristino J., Ramirez M. |
| |
|
Presence of plasmid pA15 correlates with prevalence of constitutive MLSB resistance in group A Streptococci isolates at a university hospital in southern Taiwan
|
| Liu Y-F., Fu H-M., Wu H-M., Janapatle R.P., Wang C-H., Wu J-J. |
| |
|
Presence of STa, STb and LT enterotoxin genes in Klebsiella strains isolated in different hospitals from gastrointestinal tracts
|
| Maczyñska B., Kasprzykowska U., Zychowicz A., Przondo-Mordarska A., Bartoszewicz M., Smutnicka D. |
| |
|
Present situation of antimicrobial resistance of Staphylococcus in Spain: Sixth Nationwide Prevalence Study and the in vitro activity of new antimicrobial agents
|
| Cuevas O., Cercenado E., Goyanes M., Marin M., Vindel A., Bouza E. |
| |
|
Prevalence and antimicrobial resistance of bacterial isolates in neonatal blood-stream infections
|
| Ikonomopoulou E., Vlachou M., Michail P., Paratiras S., Stavropoulou G., Verra C., Regli A. |
| |
|
Prevalence and antimicrobial susceptibility of extended-spectrum b-lactamases-producing Escherichia coli isolates from community-acquired urinary tract infections in Madrid, Spain
|
| Tamayo J., Orden B., Cacho J., Cuadros J., Gómez-Garcés J.L., Alós J.I. |
| |
|
Prevalence and antimicrobial susceptibility profiles of leading nosocomial pneumonia pathogens: the ten-year report from the European SENTRY Antimicrobial Surveillance Program
|
| Fritsche T., Sader H., Strabala P., Jones R. |
| |
|
Prevalence and antimicrobial susceptibility profiles of skin and skin structure infection pathogens in Europe: report from the SENTRY Antimicrobial Surveillance Program (19972005)
|
| Ross J., Jones R., Sader H., Stilwell M., Fritsche T. |
| |
|
Prevalence and clinical impact of Enterococcus spp. in gynaecological department
|
| Kolodjieva V., Yafaev R., Suvorov A. |
| |
|
Prevalence and diversity of bacteria in root-filled teeth associated with periradicular lesions
|
| Al-Ahmad A., Liebenow A-L., Wittmer A., Pelz K., Hellwig E., Schirrmeister J-F. |
| |
|
Prevalence and epidemiology of onychomychosis in diabetic patients in Duzce, Turkey
|
| Gulcan A., Sahin I., Yildirim M., Oksuz S., Gulcan E., Kaya D. |
| |
|
Prevalence and genetic background of fluoroquinolone resistance in clinical isolates of Proteus mirabilis
|
| Nakano R., Abe M., Inoue M., Okamoto R. |
| |
|
Prevalence and mechanisms of Streptococcus pyogenes resistance to macrolides in Moscow, Russian Federation
|
| Grudinina S.A., Filimonova O.Y., Ilina E.N., Sidorenko S.V. |
| |
|
Prevalence and molecular epidemiology of CTX-M b-lactamases in Croatia
|
| Bedenic B., Tonkic M., Jajic-Bencic I., Kalenic S., Baraniak A., Fiett J., Gniadkowski M. |
| |
|
Prevalence and molecular epidemiology of CTX-M extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in a Portuguese university hospital
|
| Da Silva G.J., Simões A.T., Tavares A., Boaventura L., Vital C., Ribeiro G. |
| |
|
Prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti in Ixodes ricinus ticks collected from the Lublin region (eastern Poland)
|
| Cisak E., Chmielewska-Badora J., Wójcik-Fatla A., Zwolinski J. |
| |
|
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among female university students in Novosibirsk, Russian Federation
|
| Khryanin A., Reshetnikov O., Anpilogova A. |
| |
|
Prevalence of Hymenolepis nana and other intestinal parasites as mixed infection among children in Ilam, and impact of single-dose praziquantel against H. nana
|
| Kaikhavandi A., Khosravi A., Dalimi Asl A. |
| |
|
Prevalence of AmpC among cephalosporin-resistant Escherichia coli and Klebsiella spp.
|
| Schønning K., Friis-Møller A., Fjeldsøe-Nielsen H. |
| |
|
Prevalence of an epidemic ESBL-producing Escherichia coli strain in LTCFs in Belfast
|
| Loughrey A., Rooney P., O'Leary M., McCalmont M., Warner M., Karisik E., Donaghy P., Smyth B., Woodford N., Livermore D. |
| |
|
Prevalence of antibodies to Trypanosoma cruzi in Latin American immigrants in Spain
|
| Portocarrero N., Baquero M., Gutierrez M. |
| |
|
Prevalence of antimicrobial resistance among Polish Campylobacter jejuni and Campylobacter coli strains isolated from humans and chicken meat
|
| Rozynek E., Dzierzanowska-Fangrat K., Korsak D., Wardak S., Szych J., Dzierzanowska D. |
| |
|
Prevalence of Chagas' disease in pregnant women from Southamerica in Valencia (Spain)
|
| Gil Brusola A., Gimenez M.J., García Y., Gomez M.D., Gobernado M. |
| |
|
Prevalence of confirmed ESBL-production among European Enterobacteriaceae: a ten-year report from the SENTRY Antimicrobial Surveillance Program
|
| Deshpande L., Jones R., Sader H., Fritsche T. |
| |
|
Prevalence of different virulence factors and in vitro adherence of Enterococcus spp. to urinary catheters
|
| Dlugaszewska J. |
| |
|
Prevalence of enteric parasites in people with and without gastrointestinal symptoms in Gonbad, Iran
|
| Nazemallhoseini-mojarad E., Mesgariyan F., Haghighi A., Zali M. |
| |
|
Prevalence of enteropathogenic and shiga toxin-producing Escherichia coli among children with and without diarrhoea in Iran
|
| Alikhani M.Y., Aslani M.M., Mirsalehian A., Fatollahzadeh B. |
| |
|
Prevalence of ESBL in the Netherlands: the ONE study
|
| Mouton J., Voss A., Arends J., Bernards on behalf of the ONE Study group S. |
| |
|
Prevalence of extended-spectrum b-lactamase-producing Enterobacteriacae isolates at two Belgian hospitals: a descriptive study
|
| Bogaerts P., Claeys G., Bauraing C., Piette A., De Vleeschauwer A., Verschraegen G., Glupczynski Y. |
| |
|
Prevalence of faecal carriage of metallo-b-lactamase producing Enterobacteriaceae in a Spanish hospital
|
| Curiao T., Tato M., Valverde A., Novais A., Baquero F., Coque T.M., Canton R. |
| |
|
Prevalence of genotypic resistance to nucleoside analogues, non-nucleoside analogues and protease inhibitors in HIV-infected persons in Athens, Greece
|
| Panos G., Charatsis G., Paparizos V., Kazantzi M., Falagas M. |
| |
|
Prevalence of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection in Madrid
|
| Fernandez-Olmos A., Mercadillo M., Moreira V., Mateos M. |
| |
|
Prevalence of hepatitis C virus genotypes in chronic infected patients of haemodialysis department
|
| Kozachenko M., Kachanka A., Samoliuk B., Karpov I. |
| |
|
Prevalence of intestinal parasitism in an urban public hospital of Madrid
|
| Monclús D., Pérez de Ayala A., Azcona J.M., Del Rey M.C., López-Brea M. |
| |
|
Prevalence of low-level quinolone resistance mediating genes in extended-spectrum b-lactamase producing Klebsiella spp. and Escherichia coli strains from Slovenia
|
| Ambrozic Avgustin J., Keber R., [Zcaron]erjavic K., Ora[zcaron]em T., Grabnar M. |
| |
|
Prevalence of methicillin-resistant Staphylococcus aureus carriage in Italian long-term care facilities
|
| Brugnaro P., Mantero J., Cazzaro R., Fedeli U., Mantoan P., Pellizzer G., Tomasini A., Zoppelletto M., Spolaore P. |
| |
|
Prevalence of methicillin-resistant Staphylococcus aureus in the southern and eastern Mediterranean final results from the ARMed project
|
| Borg M.A., Scicluna E.A., van de Sande-Bruinsma N., de Kraker M., Tiemersma E.W., Monen J., Grundmann H., Collaborators ARMed Project |
| |
|
Prevalence of methicillin-resistant Staphylococcus aureus in veterinarians: an international view
|
| Wulf M., Sorum M., van Nes A., Skov R., Melchers W., Klaassen C., Voss A. |
| |
|
Prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals: results of a multicentre survey
|
| Glupczynski Y., Behrin C., Allemeersch D., André M., De Beenhouwer H., Cartuyvels R., Frans J., Govaerts D., Joseph R., Phillipart I., Surmont I., Van den Abeele A-M., Verhaegen J., Nonhoff C., Denis O., Struelens M. |
| |
|
Prevalence of Mex-mediated resistance in Pseudomonas aeruginosa isolates from patients with ventilator-associated pneumonia in 4 Belgian hospitals
|
| Dediste A., Van Laethem Y., Jacobs F., Struelens M., De Vos D., Pirnay J., Van Bambeke F., Tulkens P., Mesaros N., Glupczynski Y., Pierard D. |
| |
|
Prevalence of MRSA in a population of ambulatory patients
|
| Szczyrek M., Kopaczewska A., Chudnicka A. |
| |
|
Prevalence of multiple-resistant Escherichia coli strains in southern and eastern Mediterranean countries
|
| Borg M.A., Scicluna E.A., de Kraker M., van de Sande-Bruinsma N., Tiemersma E.W., Monen J., Grundmann H., Collaborators ARMed Project |
| |
|
Prevalence of mutations in PBP2x of Streptococcus pneumoniae
|
| Grudinina S.A., Savinova T.A., Ilina E.N., Sidorenko S.V. |
| |
|
Prevalence of plasmid-mediated quinolone resistance determinants: qnrA, qnrB and qnrS in extended-spectrum b-lactamase producing Enterobacteriaceae strains in Hungary
|
| Szabó D., Pesti N., Kristóf K., Rókusz L., Szentandrássy J., Katona K., Nagy K. |
| |
|
Prevalence of syphilis and an examination of two syphilis rapid tests in the MCA, Cameroon
|
| Oudenaarden F., Siemerink M. |
| |
|
Prevalence of the plasmid-mediated quinolone resistance determinants qnrA, qnrB and qnrS in Enterobacteriaceae isolates causing bacteraemia
|
| Sanchez-Cespedes J., Marti S., Ruiz M., Soto S.M., Almela M., Marco F., Vila J. |
| |
|
Prevalence of thermotolerant Campylobacter species in broilers, eggs, chicken abattoir and human samples in a Hungarian county
|
| Kardos G., Mészáros J., Galántai Z., Turcsányi I., Bistyák A., Juhász Á., Damjanova I., Pászti J., Kiss I. |
| |
|
Prevalence of tuberculin reactivity among healthcare workers from an Iranian hospital
|
| Zangeneh M., Soleimany Amiry S., Jamshidi Makani M., Davar Siadat S., Haghighi S., Yarjanli M. |
| |
|
Prevenar use in children older than five years
|
| Kuli-Lito G., Sulcebe G., Ylli Z., Kallfa E. |
| |
|
Preventing healthcare-associated infections: the experience of a 3-year educational programme in the nursing homes of Trentino
|
| Caola I., Dallapè P., Scartezzini L., Noro G., Calì A., Giordani M., Negri E. |
| |
|
Prevention of Pseudomonas aeruginosa biofilm formation with antibiotics used in cystic fibrosis patients during early broncopulmonary colonisation
|
| Fernandez-Olmos A., García-Castillo M., Maiz L., Lamas A., Baquero F., Cantón R. |
| |
|
Prevention of perinatal GBS infections: impact of ChromID® StreptoB, a new chromogenic medium on suscpetibility testing
|
| Chaker W., van den Wijngaert S., Dediste A. |
| |
|
Primary and secondary resistance of Helicobacter pylori to metronidazole and azithromycin in the northern part of Croatia
|
| Maru[scaron]ic Z., Plecko V., Katicic M., [Zcaron]ele-Starcevic L., Budimir A., Bedenic B., Presecki Stanko A., Bo[scaron]njak Z., Kalenic S. |
| |
|
Primary and secondary resistance to metronidazole and clarithromycin in Spanish Helicobacter pylori clinical isolates obtained from children
|
| Cibrelus L., Alarcon T., Urruzuno P., Martinez M., Perez De Ayala A., Diaz-Regañon J., Lopez-Brea M. |
| |
|
Primary muscle hydatidosis of the thigh in a pregnant woman
|
| Degioanni M., Maccabruni A., Bolla C., Montrucchio G., Biglino A. |
| |
|
Primary resistance and treatment associated resistance to adefovir in four chronic hepatitis B patients
|
| Fernandez-Olmos A., Tato M., Moreira V., Mateos M. |
| |
|
Primary tuberculosis of the breast mimicking breast cancer
|
| Nasr B., Borzouei B., Nasserabadi A., Ahmadi M. |
| |
|
Probiotic influence of Bacillus smithii TBMI 12 against Clostridiumdifficile infection in mice and hamster model
|
| Jõgi E., Suitso I., Talpsep E., Naaber P., Lõivukene K., Nurk A. |
| |
|
Procalcitonin as a parameter for the early recognition of severe bacterial infections
|
| Georgouli A., Chinou E., Manavoglou D., Ntavlouros P., Skouteli E., Golemati P. |
| |
|
Production of an anti-biofilm molecule by Candida albicans yeasts growing as a biofilm
|
| Imbert C., Cateau E., Berjeaud J., Rodier M. |
| |
|
Production of biofilm and response to oxidative stress in Pseudomonas aeruginosa in dependence on culture media
|
| Hostacka A., Ciznar I. |
| |
|
Profile of ceftobiprole activity against S. aureus, S. pneumoniae, Enterobacteriaceae, and P. aeruginosa: results of the 20052006 Surveillance Program
|
| Aranza M.K., Draghi D.C., Jones M.E., Thornsberry C., Sahm D.F. |
| |
|
Profiling the acute inflammatory response to heat-killed menigococci and pneumococci in cerebrospinal fluid
|
| Wittwer M., Bellac C., Leib S. |
| |
|
Proinflammatory effects of erythromycin, clarithromycin and azithromycin on human endothelial cells in vitro
|
| Millrose M., Baumann-Wilschke I., Webb J., Stahlmann R. |
| |
|
Proof of specific DNA using nested-PCR in patiens with different clinical form of Lyme borreliosis
|
| Picha D., Moravcova L., Holeckova D., Sedivy K., Zdarsky E., Maresova V. |
| |
|
Prophylactic potential of high molecular weight antigenic fractions of a recent clinical isolate of L. donovani against experimental visceral leishmaniasis
|
| Tripathi P., Naik S. |
| |
|
Prophylaxis for Pneumocystis pneumonia in non-HIV immunocompromised patients: systematic review and meta-analysis
|
| Green H., Paul M., Vidal L., Leibovici L. |
| |
|
Prospective evaluation of a commercial enzyme immunoassay for the rapid antigenic detection of influenza A and B virus from paediatric respiratory samples in five consecutive influenza epidemics seasons
|
| Reina J., Ruiz de Gopegui E., Mena A., Macia M. |
| |
|
Prospective evaluation of risk factors for catheter-related bloodstream infections in two Swiss hospitals
|
| Templeton A., Rettenmund G., Schöbi B., Diethelm K., Schlegel M., Fleisch F., Henz S., Eich G. |
| |
|
Prospective, multicentre study of caspofungin for prophylaxis in high-risk liver transplantation
|
| Fortún J., Montejo M., Martín-Dávila P., Muñoz P., Cisneros J.M., Aragón C., Blanes M., Ramos A., Gavaldá J., San Juan R., Llinares on behalf of the Spanish Transplantation Infection Study Group P. |
| |
|
Prospective, randomised trial of three antiseptic solutions for prevention of central venous or arterial catheter colonisation in intensive care unit patients
|
| Vallés J., Fernández I., Alcaraz D., Chacón E., Cazorla A., Canals M., Mariscal D., Fontanals D., Morón A. |
| |
|
Prospective, randomised, double-blind, placebo-controlled phase III trial on voriconazole as primary antifungal prophylaxis during induction chemotherapy for acute myelogenous leukaemia
|
| Vehreschild J., Mousset S., Hummel M., Arenz D., Wassmer G., Harnischmacher U., Ullmann A., Buchheidt D., Böhme A., Cornely O. |
| |
|
Protein profile determination of Borrelia afzelii and Borrelia garinii isolated from skin and cerebrospinal fluid
|
| Glinsek U., Udovic T., Ruzic-Sabljic E., Strle F. |
| |
|
Protein Z, other natural anticoagulan and procalcitonin levels in adult patients with sepsis
|
| Tasdelen Fisgin N., Fisgin T., Ulger F., Esen S., Tanyel E., Zivalioglu M., Leblebicioglu H. |
| |
|
Protein D of Haemophilus influenzae the antigenic potential of a carrier protein
|
| Riesbeck K., Forsgren A., Janson H. |
| |
|
Pulmonary nocardiosis in a tertiary care hospital: 8-year experience (19992006)
|
| Papaefstathiou E., Kanellopoulou M., Skarmoutsou N., Martsoukou M., Katiska P., Papafrangas E., Tsakris A. |
| |
|
Pulmonary surfactant-associated protein alterations in subjects colonised by Pneumocystis jirovecii with idiopathic interstitial pneumonia
|
| Friaza V., de la Horra C., Respaldiza N., Montes-Cano M.A., Munoz-Lobato F., Morilla R., Rivero L., Martin-Juan J., Varela J.M., Rodriguez-Becerra E., Medrano F.J., Calderon E.J. |
| |
|
Pyomyositis in children
|
| Manoudis G., Mitsionis G., Kontogeorgakos V., Kordalis N., Sionti I., Xenakis T. |
| |
|
Pyomyositis. A current review
|
| Fernández-Fernández F.J., Pérez-Fernández S., Rubianes-González M., González-Vázquez L., Puerta-Louro R., De la Fuente-Aguado J. |
| |
|
PZ-601 antibacterial activity against well-characterised and fresh Enterobacteriaceae isolates
|
| Mezzatesta M., Trovato M., Gona F., Santagati M., Campanile F., Stefani S. |
| |
|
PZ-601 antibiotic and bactericidal activity against multidrug-resistant Gram-positive bacteria
|
| Pace J., Xerri L. |
| |
|
PZ-601 is active against both Gram-positive and Gram-negative bacterial pathogens causative for complicated skin and skin structure infections, and community-acquired pneumonia
|
| Pace J., Stevens T., Ruth B., Chua A., Kanazawa K., Young C., Xerri L. |
| |